Erratum to "Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: Role of nonoxidative metabolism" [Toxicol. Appl. Pharmacol. 216 (2006) 238-247] (DOI:10.1016/j.taap.2006.05.003);Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: Role of nonoxidative metabolism

Toxicology and Applied Pharmacology

Volumn 216, Issue 2, 2006, Pages 238-247

  Wu, Hai ^a   Cai, Ping ^a   Clemens, Dahn L ^b   Jerrells, Thomas R ^b   Ansari, G A Shakeel ^a   Kaphalia, Bhupendra S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alcohol dehydrogenase; Cytochrome P450 2E1; Ethanol; Fatty acid ethyl esters; HepG2 cells; Nonoxidative metabolism; VA 13 cells

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CYTOCHROME P450; FATTY ACID;

AEROBIC METABOLISM; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER DISEASE; MICROSOME; OXIDATION; PANCREAS DISEASE;

EID: 33749070988     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.12.010     Document Type: Erratum

References (72)

1. Agarwal D.P. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol. 49 (2001) 703-709
2. Aydin H.H., Celik H.A., Deveci R., Karacali S., Saydam G., Bedii Omay S., and Batur Y. Induction of apoptosis by fatty acid ethyl esters in HepG2 cells. Food Chem. Toxicol. 43 (2005) 139-145
3. Berild D., and Hasselbalch H. Survival after a blood alcohol of 1127 mg/dL. Lancet 2 (1981) 363
4. Bogdanffy M.S., and Taylor M.L. Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate. Drug Metab. Dis. 21 (1993) 1107-1111
5. Caro A.A., and Cederbaum A.I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 27-42
6. Carson F. Oil red O method for neutral fats. Histotechnology: A Self-Instructional Text. 2nd ed. (1990), ASCP Press, Chicago 151-152
7. Christoloupos G., Kirch E.R., and Gearien J.E. Determination of ethanol in fresh and putrefied post mortem tissues. J. Chromatogr. 87 (1973) 455-472
8. Clemens D.L., Forman A., Jerrells T.R., Sorrell M.F., and Tuma D.J. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology 35 (2002) 1196-1204
9. Criddle D.N., Raraty M.G., Neoptolemos J.P., Tepikin A.V., Petersen O.H., and Sutton R. Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolites. Proc. Natl. Acad. Sci. 101 (2004) 10738-10743
10. Cunningham C.C., Coleman W.B., and Spach P.I. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Alcohol Alcohol. 25 (1990) 127-136
11. Dai Y., Rashba-Step J., and Cederbaum A. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32 (1993) 6928-6937
12. Dan L., Cluette-Brown J.E., Kabakibi A., and Laposata M. Quantitation of the mass of fatty acid ethyl esters synthesized by HepG2 cells incubated with ethanol. Alcohol., Clin. Exp. Res. 22 (1998) 1125-1131
13. Doyle K.M., Bird D.A., Al-Salihi S., Hallaq Y., Cluette-Brown J.E., Gross K.A., and Laposata M. Fatty acid ethyl esters are present in human serum after ethanol ingestion. J. Lipid Res. 35 (1994) 428-437
14. Doyle K.M., Cluette-Brown J.E., Dube D.M., Bernhardt T.G., Morse C.R., and Laposata M. Fatty acid ethyl esters in the blood as markers of ethanol intake. J. Am. Med. Assoc. 276 (1996) 1152-1156
15. De Luca M., and McElroy W.D. Purification and properties of firefly luciferase. Methods Enzymol. 57 (1978) 1-15
16. Eguchi Y., Shimizu S., and Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57 (1997) 1835-1840
17. Eralnson C. p-Nitrophenylacetate as a substrate for carboxylester hydrolase in pancreatic juice and intestinal content. Scand. J. Gastroenterol. 5 (1970) 333-336
18. Flora S.J., and Tandon S.K. Effect of combined exposure to lead and ethanol on some biochemical indices in the rat. Biochem. Pharmacol. 36 (1987) 537-541
19. Grant B.F., Dufour M.C., and Harford T.C. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 8 (1988) 12-25
20. Hammond K.B., Rumack B.H., and Rodgerson D.O. Blood ethanol. J. Am. Med. Assoc. 226 (1973) 63-64
21. Hewitt N.J., and Hewitt P. Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 34 (2004) 243-256
22. Hoek J.B. Mitochondrial energy metabolism in chronic alcoholism. Curr. Top. Bioenerg. 17 (1994) 197-241
23. Ishii H., Adachi M., Fernandez-Checa J.C., Cederbaum A.I., Deaciuc I.V., and Nanji A.A. Role of apoptosis in alcoholic liver injury. Alcohol., Clin. Exp. Res. 27 (2003) 1207-1212
24. Jose M., Jimenez-Lopez M.P., Carrasco J.L., and Segovia C.M. Resistance of HepG2 cells against the adverse effects of ethanol related to neutral lipid and phospholipids metabolism. Biochem. Pharmacol. 63 (2002) 1485-1490
25. Kabakibi A., Morse C.R., and Laposata M. Fatty acid ethyl esters and HepG2 cells: intracellular synthesis and release from the cells. J. Lipid Res. 39 (1998) 1568-1582
26. Kaphalia B.S., and Ansari G.A.S. Fatty acid ethyl esters and ethanol-induced pancreatitis. Cell. Mol. Biol. 47 (2001) OL173-OL179
27. Kaphalia B.S., and Ansari G.A.S. Purification and characterization of rat hepatic microsomal low molecular weight fatty acid ethyl ester synthase and their relationship to carboxyl esterase. J. Biochem. Mol. Toxicol. 15 (2001) 165-171
28. Kaphalia B.S., and Ansari G.A.S. Purification and characterization of rat pancreatic fatty acid ethyl ester synthase and its structural and functional relationship to pancreatic cholesterol esterase. J. Biochem. Mol. Toxicol. 17 (2003) 245-338
29. Kaphalia B.S., Khan M.F., Carroll R.M., Aronson J., and Ansari G.A.S. Subchronic toxicity of 2-chloroethanol and 2-bromoethanol in rats. Res. Commun. Pharmacol. Toxicol. 1 (1996) 173-186
30. Kaphalia B.S., Fritz R.R., and Ansari G.A.S. Purification and characterization of rat liver microsomal fatty acid ethyl and 2-chloroethyl ester synthase and their relationship with carboxylesterase (pI 6.1). Chem. Res. Toxicol. 10 (1997) 211-218
31. Kaphalia B.S., Green S.M., and Ansari G.A.S. Fatty acid ethyl and methyl ester synthases, and fatty acid anilide synthase in HepG2 and AR42J cells: interrelationships and inhibition by tri-o-tolyl phosphate. Toxicol. Appl. Pharmacol. 159 (1999) 134-141
32. Kaphalia B.S., Cai P., Khan M.F., Okorodudu A.O., and Ansari G.A.S. Fatty acid ethyl esters in alcoholics; markers of alcohol abuse and alcoholism. Alcohol 34 (2004) 151-158
33. Kharchenko N.K. Dopamine content in blood and activity of alcohol-transforming enzymes in alcoholism. Ukr. Biokhim. Zh. 69 (1997) 87-92
34. Kukielka E., Dicker E., and Cederbaum A.I. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch. Biochem. Biophys. 309 (1994) 377-386
35. Lange L.G., and Sobel B.E. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J. Clin. Invest. 72 (1983) 724-731
36. Laposata E.A., and Lange L.G. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231 (1986) 497-499
37. Laposata E.A., Harrison E.H., and Hedberg E.B. Synthesis and degradation of fatty acid ethyl esters by cultured hepatoma cells exposed to ethanol. J. Biol. Chem. 265 (1990) 9688-9693
38. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185 (1997) 1481-1486
39. Lieber C.S. Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta 257 (1997) 59-84
40. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
41. Lindblad B., and Olsson R. Unusually high levels of blood alcohol. J. Am. Med. Assoc. 236 (1951) 1600-1602
42. Manautou J.E., and Carlson G.P. Ethanol-induced fatty acid ethyl ester formation in vivo and in vitro in rat lung. Toxicology 70 (1991) 303-312
43. Musshoff F. Chromatographic methods for the determination of markers of chronic and acute alcohol consumption. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 781 (2002) 457-480
44. 2+ activation of TLCK-sensitive proteases, and cytochrome c release. Exp. Cell Res. 269 (2001) 202-213
45. Natori S., Rust C., Stadheim L.M., Srinivasan A., Burgart L.J., and Gores G.J. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J. Hepatol. 34 (2001) 248-253
46. Neuman M.G., Cameron R.G., Shear N.H., Bellentani S., and Tiribelli C. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. Gastroenterology 109 (1995) 555-563
47. Neuman M.G., Shear N.H., Bellentani S., and Tirribelli C. Role of cytokines in ethanol-induced cytotoxicity in vitro in HepG2 cells. Gastroenterology 115 (1998) 157-166
48. Neuman M.G., Shear N.H., Cameron R.G., Katz G., and Tiribelli C. Ethanol-induced apoptosis in vitro. Clin. Biochem. 32 (1999) 547-555
49. NIAAA (National Institute on Alcohol Abuse and Alcoholism), 2000. Alcohol Health Services Research. U.S. Department of Health and Human Services, NIH. 10th Special Report to the U.S. Congress on Alcohol and Health.
50. Nicotera P., Ankarcroma M., Bonfoco E., Orrenious S., and Lipton S.A. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72 (1997) 95-101
51. Niemela O. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front. Biosci. 4 (1999) D506-D513
52. Nuutinen H., Lindros K.O., and Salaspuro M. Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcohol., Clin. Exp. Res. 7 (1983) 163-168
53. Ockner R.K. Apoptosis and liver disease: recent concepts of mechanism and significance. J. Gastroenterol. Hepatol. 6 (2001) 248-260
54. Palmer K.R., and Jenkins W.J. Aldehyde dehydrogenase in alcoholic subjects. Hepatology 5 (1985) 260-263
55. Panes J., Soler X., Pares A., Caballeria J., Farres J., Rodes J., and Pares X. Influence of liver disease on hepatic alcohol and aldehyde dehydrogenases. Gastroenterology 97 (1989) 708-714
56. Panes J., Caballeria J., Guitart R., Pares A., Sole R.X., Rodamilans M., Navasa M., Pares X., Bosch J., and Rodes J. Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics. Alcohol., Clin. Exp. Res. 17 (1993) 48-53
57. Pfutzer R.H., Tadic S.D., Li H.S., Thompson B.S., Zhang J.Y., Ford M.E., Eagon P.K., and Whitcomb D.C. Pancreatic cholesterol esterase, ES-10, and fatty acid ethyl ester synthase III gene expression are increased in the pancreas and liver but not in the brain or heart with long-term ethanol feeding in rats. Pancreas 25 (2002) 101-106
58. Purohit V., Russo D., and Coates P.M. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 34 (2004) 3-8
59. Ramaiah S., Rivera C., and Arteel G. Early-phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis. Int. J. Toxicol. 23 (2004) 217-231
60. Riley D.J.S., Kyger E.M., Spilburg C.A., and Lange L.G. Pancreatic cholesterol esterases. 2. Purification and characterization of human pancreatic fatty acid ethyl ester synthase. Biochemistry 29 (1990) 3848-3852
61. Rognstead R., and Grunnet N. Enzymatic pathways of ethanol metabolism. In: Majchrowicz E., and Noble E.P. (Eds). Biochemistry and Pharmacology of Ethanol (1979), Plenum Press, New York 65-86
62. Sharkawi M. In vivo inhibition of liver alcohol dehydrogenase by ethanol administration. Life Sci. 35 (1984) 2353-2357
63. Shore J.D., and Theorell H. Substrate inhibition effects in the liver alcohol dehydrogenase reaction. Arch. Biochem. Biophys. 117 (1966) 375-380
64. Soderberg B.L., Salem R.O., Best C.A., Cluette-Brown J.E., and Laposata M. Fatty acid ethyl esters. Ethanol metabolites that reflect ethanol intake. Am. J. Clin. Pathol. 119 (2003) S94-S99 (Suppl.)
65. Sorensen T.I., Orholm M., Bentsen K.D., Hoybye G., Eghoje K., and Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2 (1984) 241-244
66. Strassnig S., and Lankmayr E.P. Elimination of matrix effects for static headspace analysis of ethanol. J. Chromatogr. 849 (1999) 629-636
67. Werner J., Laposata M., Fernandez-del Castillo C., Saghir M., Iozzo R.V., Lewandrowski K.B., and Warshaw A.L. Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology 113 (1997) 286-294
68. Werner J., Saghir M., Warshaw A.L., Lewandrowski K.B., Laposata M., Iozzo R.V., Carter E.A., Schatz R.J., and Fernandez-Del Castillo C. Alcoholic pancreatitis in rats: injury from nonoxidative metabolites of ethanol. Am. J. Physiol.: Gastrointest. Liver Physiol. 283 (2002) G65-G73
69. Wolfla C.E., Ross R.N., and Crabb D.W. Induction of alcohol dehydrogenase activity and mRNA in hepatoma cells by dexamethasone. Arch. Biochem. Biophys. 263 (1988) 69-76
70. Worner T.M., and Lieber C.S. Perivenular fibrosis as precursor lesion of cirrhosis. J. Am. Med. Assoc. 254 (1985) 627-630
71. Wu D., and Cederbaum A.I. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Alcohol., Clin. Exp. Res. 23 (1999) 67-76
72. Zahlten R.N., Jacobson C.J., and Neijtek M.E. Underestimation of alcohol dehydrogenase as a result of various technical pitfalls of the enzyme assay. Biochem. Pharmacol. 29 (1980) 1973-1976